Tirzepatide Constipation: What to Check and When to Get Help

Constipation is a common reported side effect of tirzepatide, including Zepbound. It is worth addressing early, but “common” does not mean every episode is harmless or that you should manage a severe change with stronger and stronger laxatives.

The useful questions are what has changed from your normal bowel pattern, whether warning symptoms are present, and what treatment fits your health history. This guide explains the evidence and how to prepare that discussion without prescribing a laxative regimen or a medication dose change.

How common was constipation in Zepbound trials?

In the pooled weight-reduction trials reported in Zepbound's current label, constipation or hard stools occurred in 17% at 5 mg, 14% at 10 mg, and 11% at 15 mg, versus 5% with placebo.¹

These are reported adverse-event proportions over the studies, not your probability of being constipated after each injection. The descending percentages are not a reason to increase the dose to treat constipation. Different dose groups and the study's reporting cannot establish that strategy.

The figures describe approved Zepbound under trial conditions. They do not measure every compounded tirzepatide formulation or prove that a service's particular product has the same tolerability. Our tirzepatide guide separates those product questions.

Recognize a change, not just a missed daily movement

Constipation can include hard or lumpy stool, difficulty or pain passing stool, a feeling of incomplete emptying, or fewer than three bowel movements a week. Your usual pattern matters; a daily bowel movement is not the only definition of normal.²

Record the last comfortable bowel movement, stool consistency, straining, pain, and whether you can pass gas. Also note the medication start or increase date, food and fluid intake, and other medicines or supplements. This gives a clinician more useful information than a single statement that digestion has slowed.

Tirzepatide delays stomach emptying, but constipation concerns stool passage through the bowel. It does not, by itself, establish a stomach-emptying disorder. Our gastroparesis guide explains why persistent upper-digestive symptoms require their own assessment.

Symptoms that should not wait for a routine message

NIDDK advises prompt medical attention when constipation accompanies constant abdominal pain, vomiting, inability to pass gas, fever, rectal bleeding, or blood in stool.² A combination of severe pain, swelling, vomiting, or inability to pass gas should not be treated as an invitation to try a home purge.

Zepbound's postmarketing section includes severe constipation with fecal impaction, ileus, and intestinal obstruction. Voluntary reports cannot reliably establish their frequency or prove that the drug caused an individual event.¹ They do reinforce why severe symptoms need assessment rather than an assumption that all constipation is routine.

If symptoms are serious or rapidly worsening, seek urgent care rather than waiting for a subscription service's next available appointment. The broader side-effect guide helps distinguish common complaints from warning signs.

What you can review with the care team

For uncomplicated constipation, clinicians commonly review dietary fiber, fluids, activity, and toileting habits. NIDDK advises increasing fiber gradually and drinking enough fluid to help it work; individual fluid restrictions and health conditions still matter.³

Avoid suddenly forcing large amounts of fiber when you are significantly bloated, vomiting, or experiencing pain. Ask whether a gradual food change is suitable and whether a pharmacist or clinician recommends a particular over-the-counter option for your situation.

Different laxative categories work differently. A product recommended to a friend may be unsuitable with your kidney disease, other medicines, or current symptoms. Repeated stimulant use, multiple combined products, enemas, or large cleansing doses should not substitute for evaluation of persistent symptoms. This article does not recommend a dose or sequence of laxatives.

Check other medicines and the refill plan

Bring every prescription, over-the-counter product, and supplement to the discussion, including anything newly added. Other medicines can contribute to constipation, and a treatment may need a broader review than attributing everything to tirzepatide.² Our interaction guide explains why the exact medication list matters.

Do not independently accelerate, skip, or reduce tirzepatide to solve the problem. Tell the prescriber before the next planned increase if symptoms remain troublesome, and request an individualized plan. A weight-loss plateau is not a reason to dismiss constipation or assume that more medication is required.

If constipation accompanies unusual tiredness or difficulty maintaining intake, describe both symptoms. Our why fatigue can occur during tirzepatide treatment covers trial rates and the reasons not to attribute every low-energy day to the injection.

Ask for follow-up that is specific

Agree on what improvement to expect, when to report back, and which symptoms require urgent assessment. If the first approach does not help, the answer should be reassessment rather than indefinite escalation of home remedies.

Use our provider checklist to ask about access between renewals. A practical constipation plan includes a reachable clinician, clear instructions, and attention to nutrition and hydration—not merely another refill.

If loose stools follow constipation treatment, tell the clinician which laxatives or supplements you used. Our diarrhea and dehydration guide covers that change in symptoms, while the kidney-risk guide explains why fluid losses and other medicines deserve attention.